ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada.
Promis Neurosciences stock last closed at $0.59, up 4.81% from the previous day, and has decreased 69.85% in one year. It has overperformed other stocks in the Biotechnology industry by 0.08 percentage points. Promis Neurosciences stock is currently +15.07% from its 52-week low of $0.51, and -75.19% from its 52-week high of $2.37.
As of Apr 25, 2025, there are 32.69M shares of PMN outstanding. The market cap of PMN is $19.22M. In the last 24 hours, 20,920 PMN shares were traded.
How to Buy Promis Neurosciences Stock
Wondering how to invest in Promis Neurosciences stock? Here's how.
Choose where to buy Promis Neurosciences stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Promis Neurosciences stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Fund your investment account: Pick your method of payment and add your information.
Research Promis Neurosciences stock: The Promis Neurosciences ticker symbol is PMN. Is Promis Neurosciences stock a good investment? Should you buy shares of PMN? How do PMN's underlying business fundamentals look? Do top analysts think Promis Neurosciences is a good buy? Why has PMN's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if PMN is a good stock to buy).
Make your PMN purchase: Decide if you will purchase PMN shares at the current market price or use a limit order to buy PMN stock at a particular price.
Watch your investment in PMN: Create a watchlist to key updates about your position in Promis Neurosciences stock.
Step 1: Choose where to buy Promis Neurosciences stock
You need a brokerage account in order to access the NASDAQ market and buy PMN shares.
A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to world financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal details so you are able to invest in PMN today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Promis Neurosciences stock
After you have identified the best place to buy Promis Neurosciences stock, it's absolutely critical to research their stock before you invest, so you truly wrap your head around the risk and upside.
Promis Neurosciences Metrics
PMN Price
$0.59
1w %
3.7%
1y %
-69.85%
5y %
N/A
P/E
5.35x
P/B
1.17x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
$2.78M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$19.22M
Next Earnings
May 12, 2025
Next Dividend
N/A
PMN Due Diligence Score
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on PMN's stock page.
Is PMN stock undervalued or overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PMN's fair value.
Using relative valuations methods:
PMN could be undervalued based on its P/E ratio of 5.35x, relative to Biotechnology industry P/E ratio of -157.91x
PMN may be undervalued based on its P/B ratio of 1.17x, relative to Biotechnology industry P/B ratio of 4.26x
No, Promis Neurosciences doesn't provide an income stream by paying out dividends.
What others are saying about PMN
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Make your PMN purchase
You have two primary types of orders:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are generally the best for newer investors.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a given dollar amount limit, use a limit order.
Click the Open Trade button and eToro will place the order.
If you want additional help buying stocks on eToro, click the helpful video below:
How much does it cost to buy one Promis Neurosciences share?
As of Apr 25, 2025, it costs $0.59 to buy one share of Promis Neurosciences stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.29, you can buy 0.5 shares of PMN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.